Endovascular Therapy

in Overview of Vascular Disease

Applied

Type

Addition

Confidence

80%

Created

Mar 27, 2026

Evidence

1 source

Rationale

The section was updated to include REBOA and angioembolization for pelvic trauma, reflecting the evidence from Anand et al. (2022) which analyzed hemorrhage control interventions in a large trauma cohort. Abbreviations were expanded on first use (DCB, DES, ALI, REBOA) to comply with the style guidelines.

Content Changes

* **percutaneous transluminal angioplasty (PTA):** Widely used for focal lesions, especially in iliac arteries.
* **Drug-coated devicesdevices:** (DCB/DES):**Drug-coated Improveballoons (DCB) and drug-eluting stents (DES) improve patency in femoropopliteal disease; see [[Peripheral Artery Disease|Ch. 10]] for evidence and paclitaxel safety considerations.
* **endovascular aneurysm repair (EVAR)/thoracic endovascular aortic repair (TEVAR):** Reduced perioperative mortality compared to open repair; see [[Aneurysmal Diseases|Ch. 4]] for RCT evidence and patient selection.
* **Thrombectomy:** Penumbra Indigo and AngioJet systems effective in acute limb ischemia (ALI) [@hsiao2019].
* **Embolization:** Indicated for visceral aneurysms, endoleaks, hemorrhage.and hemorrhage control, including arterial embolization for hemodynamically unstable pelvic fractures [@anand2022].
* **resuscitative endovascular balloon occlusion of the aorta (REBOA):** Utilized for temporary hemorrhage control in trauma patients with life-threatening subdiaphragmatic bleeding, often as part of a multi-modal approach alongside angioembolization or surgery [@anand2022].

> **See Also:** Disease-specific techniques: [[Aneurysmal Diseases|Ch. 4]], [[Peripheral Artery Disease|Ch. 10]], [[endovascular trauma management (EVTM)|Ch. 16]].